Modern Chinese Medicine Group Co (HKSE:01643) Marketable Securities: HK$0.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01643 Modern Chinese Medicine Group Co Ltd HKSE:01643
50 GF Score
Price HK$0.83
GF Value HK$0.15
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Modern Chinese Medicine Group Co Marketable Securities?

Modern Chinese Medicine Group Co HKSE:01643 +0.61% 50 Marketable Securities is HK$0.0 Mil as of Dec. 2025. GuruFocus rates HKSE:01643 with a GF Score™ of 50/100 and a GF Value™ of HK$0.15 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Modern Chinese Medicine Group Co's Marketable Securities for the quarter that ended in Dec. 2025 was HK$0.0 Mil.

Modern Chinese Medicine Group Co  (HKSE:01643) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Modern Chinese Medicine Group Co Marketable Securities Related Terms

Modern Chinese Medicine Group Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Modern Chinese Medicine Group Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Modern Chinese Medicine Group Co Marketable Securities Chart

Modern Chinese Medicine Group Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Modern Chinese Medicine Group Co Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HKSE:01643
50GF Score
Modern Chinese Medicine Group Co Ltd HKSE:01643
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Modern Chinese Medicine Group Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of HK$0.0 Mil mean?
Modern Chinese Medicine Group Co (HKSE:01643) has a Marketable Securities of HK$0.0 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Modern Chinese Medicine Group Co and its competitors.
Is Modern Chinese Medicine Group Co's Marketable Securities too high?
Modern Chinese Medicine Group Co's current Marketable Securities is HK$0.0 Mil. Overall, Modern Chinese Medicine Group Co has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Modern Chinese Medicine Group Co's Marketable Securities compare to LLY and JNJ?
Modern Chinese Medicine Group Co's Marketable Securities of HK$0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Modern Chinese Medicine Group Co and its competitors. Modern Chinese Medicine Group Co's current Marketable Securities is HK$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Modern Chinese Medicine Group Co stock overvalued right now?
Based on GuruFocus' analysis, Modern Chinese Medicine Group Co (HKSE:01643) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.15, compared to a current price of HK$0.83 — trading 453.3% above its estimated fair value. The current Marketable Securities is HK$0.0 Mil. Modern Chinese Medicine Group Co's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Modern Chinese Medicine Group Co (HKSE:01643), the current Marketable Securities is HK$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Modern Chinese Medicine Group Co (HKSE:01643) Overvalued in 2026?

Based on GuruFocus' analysis, Modern Chinese Medicine Group Co stock appears to be overvalued. The current stock price of HK$0.83 is trading 453.3% above its estimated GF Value™ of HK$0.15. GuruFocus considers Modern Chinese Medicine Group Co to be Significantly Overvalued.

Key valuation signals for HKSE:01643:

  • Marketable Securities: HK$0.0 Mil
  • GF Value™: HK$0.15 vs. price of HK$0.83 (453.3% above fair value)
  • GF Score™: 50/100 with 3 warning signs

No single metric tells the full story. See the HKSE:01643 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Modern Chinese Medicine Group Co Business Description

Address No. 88 Jinwei Road, Hebei Province, Longhua County, Chengde, CHN, 068150
Modern Chinese Medicine Group Co Ltd is engaged in the production of Proprietary Chinese Medicines. It offers both OTC and prescribed medicines intended for use by the Middle-aged and the Elderly in the PRC. Its products include liver protection tablets, Shanmei capsules, Qi and blood supplement pills, and Xiaohuoluo pills, among others. Geographically, the company derives its key revenue from the People's Republic of China.
50GF Score

Get the complete analysis for HKSE:01643

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.83
Price
HK$0.15
GF Value